physics-informed AI
Small Molecules, Big Data: The AI-Powered Future of Oral Obesity Therapies
PRISM BioLab and Receptor.AI Partner to Navigate the Undruggable PPI Landscape On March 12, 2026, Tokyo-based PRISM BioLab and U.S.-based TechBio firm Receptor.AI announced a strategic collaboration to build an integrated, AI-navigated drug discovery platform. This partnership aims to solve one of the most persistent challenges in pharmacology: the discovery of orally available small molecules…
ZENN AI: Betting on Clarity in a Noisy Data Economy
AI is supposed to make sense of complicated stuff, right? Scans, lab results, materials data, all that. But here’s the thing. It often struggles when the data aren’t perfect. And real-world data almost never are. Different labs, different machines, even the same experiment on a different day can give slightly different numbers. Most AI models…
